Molina Healthcare (NYS:MOH) has made several significant developments in recent times. It expanded its credit agreement by securing a US$500M delayed draw commitment and completed the acquisition of ConnectiCare, thereby absorbing its robust member base of about 140K. Revenue targets were shattered as the company set an ambitious $42B goal for 2025. Investors that jumped on board five years ago saw a yield of 144%. The company also announced the pricing of $750 million of 6.250% Senior Notes due 2033, raising $750M. However, Q4 earnings missed estimates due to escalating medical costs but the company's EPS and strategic growth remain strong. Molina Healthcare's stock outlook remains uncertain amid medicaid uncertainties, but performs well under hedge funds. The company was also highlighted as one of Michael Burryβs top 10 stock picks, an analytical factor that could influence investors seeking industry advice. Yet, a SWOT analysis reveals a potential risk due to higher quarterly Medicaid costs. The price target has been lowered to $340 from $370 at Truist and to $295 from $340 at Wells Fargo which may reflect perceived limitations in growth.
Molina Healthcare MOH News Analytics from Fri, 19 Jul 2024 07:00:00 GMT to Sat, 22 Feb 2025 17:48:11 GMT -
Rating 1
- Innovation -2
- Information 4
- Rumor -3
